Apoptosis and Senescence in Localized Prostate Cancer Tissues Treated With HDR-BT Boost With Radiotherapy (EBRT) and ADT

被引：0
|
作者：
Chebra, I. [1 ]
机构：
[1] CHU Quebec, Quebec City, PQ, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2518
引用
收藏
页码：E258 / E258
页数：1
相关论文
共 50 条
  • [31] Does prostate volume has an impact on biochemical failure in patients with localized prostate cancer treated with HDR boost?
    Vigneault, Eric
    Mbodji, Khaly
    Beaudet, Marc-Etienne
    Despres, Philippe
    Lavallee, Marie-Claude
    Martin, Andre-Guy
    Foster, William
    Aubin, Sylviane
    Beaulieu, Luc
    RADIOTHERAPY AND ONCOLOGY, 2016, 121 (02) : 304 - 309
  • [32] UNDER-UTILIZATION OF HIGH-DOSE-RATE BRACHYTHERAPY (HDR-BT) WITH EXTERNAL BEAM RADIOTHERAPY (EBRT) IN THE POPULATION-BASED PROSTATE CANCER OUTCOMES REGISTRY VICTORIA (PCOR-VIC)
    Ong, Wee Loon
    Evans, Sue
    Millar, Jeremy
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 51 - 52
  • [33] Multiparametric imaging guided HDR interventional radiotherapy (brachytherapy) boost in localized prostate cancer: a multidisciplinary experience
    Tagliaferri, L.
    Alemanno, G.
    Fionda, B.
    Alitto, A. R.
    Frascino, V.
    Cellini, F.
    Lancellotta, V.
    Placidi, E.
    Morganti, A. G.
    Kovacs, G.
    Giordano, A.
    Manfredi, R.
    Valentini, V.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (09) : 4175 - 4184
  • [34] Importance of PSA Level Post-Neoadjuvant Androgen Deprivation Therapy (ADT) for Patients With Prostate Cancer (PC) Treated With External Beam Radiation Therapy (EBRT) and Brachytherapy HDR Boost
    Milecki, P.
    Rucinska, A.
    Adamska, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S436 - S436
  • [35] COMBINED RADIOTHERAPY OF PROSTATE CANCER: HDR BOOST VS LDR BOOST.
    Albitskiy, I.
    Vinikovetskaya, A.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S281 - S281
  • [36] Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer
    Galalae, RM
    Martinez, A
    Mate, T
    Mitchell, C
    Edmundson, G
    Nuernberg, N
    Eulau, S
    Gustafson, G
    Gribble, M
    Kovács, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (04): : 1048 - 1055
  • [37] HDR Brachytherapy Combined to EBRT and ADT for Prostate Cancer: Analysis of Toxicities and Quality of Life in a Phase 2 Trial
    Tetreault, A.
    Nguyen-Huynh, T. V.
    Vincent, F.
    Saad, F.
    Benoit, N.
    Fortin, B.
    Lambert, C.
    Jolicoeur, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E214 - E215
  • [38] HDR brachytherapy boost plus EBRT in unfavorable prostate cancer: results in more then 700 patients
    Ribeiro, Ivone
    Ignacio Rodriguez-Melcon, Juan
    Ferrandiz, Victor
    Federico, Mario
    Zafra-Martin, Juan
    Dominguez Dominguez, Alba
    Aguiar Santana, Daniel
    Luis Perez-Molina, Juan
    Rodriguez-Serafin, Eduardo
    Tornero, Ana
    Morato Garcia, Victoria
    Pinar, Beatriz
    Lloret, Marta
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S431 - S432
  • [39] MRI guided focal primary and (secondary) salvage HDR-BT in prostate cancer patients seems safe
    Maenhout, M.
    Moerland, M. A.
    Van Vliet-van den Ende, K. M.
    Schokker, R. I.
    de Battisti, M. Borot
    Peters, M.
    Van Vulpen, M.
    van Zyp, J. R. N. Van der Voort
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S16 - S17
  • [40] Does Phoenix Failure Definition Apply to EBRT plus HDR Brachytherapy Boost in Prostate Cancer?
    Martin, A. G.
    Vigneault, E.
    Foster, W.
    Aubin, S.
    Beaulieu, L.
    Despres, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S415 - S416
12345